tradingkey.logo
tradingkey.logo
Suchen

Cibus Inc

CBUS
Zur Watchlist hinzufügen
1.390USD
-0.030-2.11%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
106.03MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Cibus Inc Unternehmen

Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.

Cibus Inc Informationen

BörsenkürzelCBUS
Name des UnternehmensCibus Inc
IPO-datumJul 20, 2017
CEOBeetham (Peter Ronald)
Anzahl der mitarbeiter157
WertpapierartOrdinary Share
GeschäftsjahresendeJul 20
Addresse6455 Nancy Ridge Drive
StadtSAN DIEGO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl92121
Telefon18584500008
Websitehttps://www.cibus.com/
BörsenkürzelCBUS
IPO-datumJul 20, 2017
CEOBeetham (Peter Ronald)

Führungskräfte von Cibus Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.96M
--
Mr. Craig Wichner
Mr. Craig Wichner
Director
Director
894.31K
--
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
592.70K
+38.19%
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
139.88K
+27.17%
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
104.94K
+61.70%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
85.47K
-35.32%
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
--
--
Mr. Cornelis (Carlo) Broos
Mr. Cornelis (Carlo) Broos
Chief Financial Officer
Chief Financial Officer
--
--
Mr. August J. Moretti, J.D.
Mr. August J. Moretti, J.D.
Independent Director
Independent Director
--
--
Ms. Kimberly Ann (Kim) Box
Ms. Kimberly Ann (Kim) Box
Director
Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.96M
--
Mr. Craig Wichner
Mr. Craig Wichner
Director
Director
894.31K
--
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
592.70K
+38.19%
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
139.88K
+27.17%
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
104.94K
+61.70%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
85.47K
-35.32%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Cibus Inc?

Die fünf größten Anteilseigner von Cibus Inc sind: Mr. Rory B. Riggs

Wie viele Institutionen halten Anteile an Cibus Inc (CBUS)?

Mit Stand vom 2026Q1 halten 162 Institutionen Anteile an Cibus Inc, mit einem Gesamtmarktwert von etwa 12.20M, was 16.60% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -2351528.00 gestiegen.